Your browser doesn't support javascript.
loading
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Gregersen, Henrik; Peceliunas, Valdas; Remes, Kari; Schjesvold, Fredrik; Abildgaard, Niels; Nahi, Hareth; Andersen, Niels Frost; Vangsted, Annette Juul; Klausen, Tobias Wirenfeldt; Helleberg, Carsten; Carlson, Kristina; Frølund, Ulf Christian; Axelsson, Per; Stromberg, Olga; Blimark, Cecilie Hveding; Crafoord, Jacob; Tsykunova, Galina; Eshoj, Henrik Rode; Waage, Anders; Hansson, Markus; Gulbrandsen, Nina.
Afiliación
  • Gregersen H; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.
  • Peceliunas V; Department of Haematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Remes K; Department of Haematology, Turku University Hospital, Turku, Finland.
  • Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
  • Abildgaard N; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
  • Nahi H; Department of Haematology, Odense University Hospital, Odense, Denmark.
  • Andersen NF; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Vangsted AJ; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
  • Klausen TW; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
  • Helleberg C; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Carlson K; Department of Haematology, Herlev Hospital, Herlev, Denmark.
  • Frølund UC; Department of Haematology, Herlev Hospital, Herlev, Denmark.
  • Axelsson P; Department of Haematology, Uppsala University Hospital, Uppsala, Sweden.
  • Stromberg O; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
  • Blimark CH; Department of Haematology, Helsingborg Hospital, Helsingborg, Sweden.
  • Crafoord J; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
  • Tsykunova G; Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Eshoj HR; Department of Haematology, Örebro University Hospital, Örebro, Sweden.
  • Waage A; Department of Haematology, Haukeland University Hospital, Bergen, Norway.
  • Hansson M; Quality of Life Research Center, Department of Haematology, Odense University Hospital, Odense, Denmark.
  • Gulbrandsen N; OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Denmark.
Eur J Haematol ; 108(1): 34-44, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34536308
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca